Tirzepatide is an innovative dual GIP/GLP-1 receptor stimulator. This medication has shown remarkable results in clinical trials for the treatment of type 2 diabetes. By targeting both the GIP and GLP-1 receptors, https://ammarqcyw090697.blognody.com/49063435/tirzepatide-a-novel-dual-gip-glp-1-receptor-agonist